A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts said the demand for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking fines, legal action or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has removed violative material and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at home.
After minutes of joining one group, a seller posted WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.
Product Details and Pricing
Inside these groups, messages show dark colored parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.
